The Endocrine Society continues to advocate for physician payment and telehealth policies important to Society members. In September, the Society submitted comments on the Medicare Physician Fee Schedule (MPFS) proposed rule for calendar year 2022. This annual rule updates payment policies and payment rates for Part B services furnished under the MPFS. In our letter,...
The Endocrine Society has launched a series of educational briefings for congressional offices about endocrine research. On March 30, we hosted a virtual congressional briefing on COVID-19 and diabetes. Our panel included Congresswoman Kim Schrier (WA-08), the only U.S. Representative living with type 1 diabetes and a pediatrician; director of the National Institutes of...
On March 16, the Endocrine Society conducted a “virtual” Research Hill Day where Endocrine Society members from across the U.S. met with their congressional representatives and their staff through Zoom, Skype, conference lines, and other electronic meeting platforms while the Capitol complex is closed for the pandemic and security reasons. During these meetings, Endocrine Society members urged Congress to provide an increase...
On December 1, 2020, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) final rule for CY 2021. This rule updates payment policies and payment rates for Part B services furnished under the MPFS, as well as makes changes to the Quality Payment Program. As a result of changes included...
It took weeks of intense, protracted negotiation, but just days before Christmas, House and Senate leaders finally clinched an agreement to send a massive end-of-year legislative package, including $900 billion in coronavirus relief, a $1.4 trillion spending bill to fund all federal agencies until the end of September 2021, and extension of the Special Diabetes...
As 2020 winds down, Endocrine News is taking a quick jaunt down memory lane to focus on the many accomplishments the Endocrine Society had over the course of the last 12 months. Despite various obstacles and upended plans, 2020 turned out to be a remarkable year for progress and successful new endeavors. We were somewhere...
The Endocrine Society is an advocate for transgender patients and ensuring their access to gender-affirming, evidence-based healthcare. During the Fall, the Society’s Transgender Special Interest Group and members of the Pediatric Endocrine Society formed a working group to update Society documents and develop new material on care for transgender individuals to be used in advocacy...
In the wake of Joe Biden’s win of the 2020 presidential election, the Endocrine Society has looked at what a change in presidential administration could mean for its policy agenda and provided a few predictions: Immediate Priorities The “lame duck” period and first 100 days of a Biden Administration will likely be dominated by urgent efforts...
In the wake of Joe Biden’s win of the 2020 presidential election, the Endocrine Society has looked at what a change in presidential administration could mean for its policy agenda and provided a few predictions: Immediate Priorities The “lame duck” period and first 100 days of a Biden Administration will likely be dominated by urgent efforts...
